"We're here to save lives," said Geoff Benic, CEO at Safety Strips Inc., a company at the forefront of harm reduction in the midst of the opioid pandemic.
Benic was one of the pioneering CEOs who joined Michael Astone, CEO at ArcStone Securities & Investments Corp, in a discussion about the third wave of rescheduling narcotics and plant medicine at the recent Benzinga Cannabis Capital Conference (CCC) in Chicago.
See Also: ArcStone Securities To Acquire Arcview Capital, Betting Big On Cannabis Industry
Safe Supply’s Global Approach
Bill Panagiotakopoulos, CEO of Safe Supply Streaming Co. Ltd, said he believes in taking a global approach to addressing the rescheduling of narcotics.
He noted the significant shift in the perception of drugs over the years, from cannabis to psychedelics, and now to the rescheduling of various substances.
Safe Supply Streaming focuses on investing in companies worldwide that are exploring the potential of MDMA, ecstasy, psilocybin, and even substances like cocaine for therapeutic purposes.
"We take a global approach to our core investments. We're looking at companies in Australia that are in the MDMA, ecstasy, and psilocybin marketplace. We're looking at Bern, Switzerland, that is promoting the motion to decriminalize and sell legal cocaine," said Panagiotakopoulos.
See Also: Australia Psychedelics Recent News
Harbor's Quest To Unlock The Power Of The Coca Plant
Setti Coscarella, VP of corporate development at Safe Supply and member board of directors ...